Canexis Pharma AG, a Swiss manufacturer supplying EU-GMP cannabinoid APIs (CBD, dronabinol/THC) with QP release, BtM compliance, and full regulatory documentation (CoA, stability data, and risk assessments).

Company (Headquarters):

Switzerland

Company Products and Services:

Active Pharmaceutical Ingredients;CMO/CDMO

Number of Facilities:

1

Facilities Location:

Europe

Regulatory Approvals for facilities:

Europe – EMA or constituent countries;GMP;ISO 9001